Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Zardaverine exhibits potent and selective antitumor activity against hepatocellular carcinoma both in vitro and in vivo independently of phosphodiesterase inhibition
Formula: C13H8N6
and used to treat a wide variety of infections
Solubility: DMSO 85 mg/mL (200
Binding to cell membranes and plasma proteins may be involved in the compound's cytotoxic effects
Icotinib Hydrochloride - CAS# 1204313-51-8 Size:Solid 10 mg Zardaverine exhibits potent and selectiveIcotinib, also known as BPI 2009, is an orally available quinazoline based inhibitor of epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Icotinib selectively inhibits the wild type and several mutated forms of EGFR tyrosine kinase. This may lead to an inhibition of EGFR mediated signal transduction and may inhibit cancer cell proliferation. EGFR, a receptor tyrosine kinase, is upregulated in a variety of cancer cell